feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

Delhi pollution source study ordered

trending

Markets decline on fund outflows

trending

India-South Africa betting arrests

trending

Starlink announces India pricing

trending

Rahane slams 95 for Mumbai

trending

SSC CGL Tier 1 results

trending

Japan earthquake triggers tsunami alert

trending

Praggnanandhaa wins FIDE Circuit

trending

Accenture: AI gift inspiration

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / UK urged to fund Aids fight amid global aid cuts

UK urged to fund Aids fight amid global aid cuts

25 Nov

•

Summary

  • UNAIDS chief urges UK to fight Aids pandemic with new drugs.
  • Massive funding cuts from US, Europe, and UK disrupt services.
  • New prevention drugs like Lenacapavir offer near-total protection.
UK urged to fund Aids fight amid global aid cuts

UNAIDS Executive Director Winnie Byanyima has called on the UK to "fight to the finish line" against the Aids pandemic, citing the availability of revolutionary prevention drugs. She expressed alarm over unprecedented global aid reductions from the US, Europe, and the UK, which have severely disrupted HIV/Aids services worldwide. These cuts threaten to reverse progress and lead to millions more deaths and infections, alongside an increase in drug-resistant strains.

The crisis has been exacerbated by significant funding withdrawals, notably from the US's PEPFAR program and the UK's contribution to the Global Fund. While the US has reinstated some funding with conditions, the UK's planned cuts to foreign aid spending are a major concern. Byanyima highlighted that new tools, such as the injectable Lenacapavir offering nearly 100% efficacy, could virtually eliminate new infections, but require scaled-up access.

The UNAIDS chief stressed that ending the pandemic is a global imperative, as failure to do so allows the virus to incubate and potentially re-emerge elsewhere. She appealed to the UK, a long-standing supporter, to protect remaining funding, particularly for vulnerable populations like teenage girls, young women, and high-risk groups, whose access to vital reproductive health and education services is threatened by these financial cutbacks.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Lenacapavir is a new injectable drug offering nearly 100% efficacy in preventing HIV infections, administered twice yearly.
Massive funding cuts from major donors like the US, Europe, and the UK have severely impacted essential HIV/Aids prevention and treatment programs.
Reductions in UK foreign aid risk undermining global efforts to end Aids, potentially leading to more deaths, infections, and drug-resistant strains.

Read more news on

Healthside-arrow

You may also like

Spyware Firm's Secret Remote Access Exposed

4 Dec • 13 reads

article image

December Dominates: India's New Film Release Crown

1 Dec • 25 reads

article image

GLP-1 Drugs Slash Colon Cancer Deaths by Over 50%, Study Finds

13 Nov • 73 reads

article image

Bloodbath at the Festive Table: PETA's Chilling 2025 Christmas Ad

12 Nov • 51 reads

article image

Roche's Experimental MS Drug Succeeds in Late-Stage Trial

11 Nov • 83 reads

article image